Wellesley Investment Advisors »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Wellesley Investment Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Wellesley Investment Advisors from 13F filings

Historical chart of Wellesley Investment Advisors investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Wellesley Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Wellesley Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2B 1.0M 1191.37
2024-06-30 $1.6B 1.4M 1112.66